Could Ozempic help people whose cancer has spread to the brain?
Weight-loss injections that have become famous for helping people shed pounds may also help some patients with advanced cancer live longer when the disease has spread to the brain, according to a new study.
Weight loss drug Ozempic cuts depression, anxiety, and addiction risk
GLP-1 medications like semaglutide (Ozempic) may offer unexpected mental health benefits alongside weight loss. A large study found major drops in depression, anxiety, and psychiatric-related hospital visits among users. Even substance use disorders were significantly lower during treatment. Researchers suspect both lifestyle improvements and direct brain effects could be at play.
GLP-1 drugs and low-carb diets leave Americans short on fiber as protein craze grows, experts warn
Protein products are flooding grocery shelves as influencers promote high-protein diets, but nutrition experts caution the anti-carb trend oversimplifies eating.
Roche, Nvidia’s ‘AI Factory’; Industry looks to soften MFN impact; Structure’s oral GLP-1 data; and more
Welcome to another edition of Endpoints Weekly — and happy spring! The weather may not feel very spring-like here in NYC (outside that false start a couple weeks ago), but we’re grateful the sidewalk snowbanks are …
Stopping Ozempic, Wegovy May Reverse Cardiovascular Benefits
Stopping GLP-1s can quickly reverse the cardiovascular benefits gained while taking them. Image Credit: the_burtons/Getty Images
A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.
The findings show that stopping the medications for as little as 6 months raises the risk of heart attack and stroke.
Weight-loss drug semaglutide does not slow Alzheimer’s disease, two clinical trials find
Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer’s disease, finds the first large Phase III randomized controlled trials on the topic published in The Lancet.
Almost half of those stopping GLP-1 weight-loss drugs keep the weight off
Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
FRIDAY, March 20, 2026 — Drugs like Ozempic and Mounjaro are known to lower the risk of heart attack and stroke, but a new study suggests those benefits may not last if people stop taking them.Researchers found that heart risks begin to rise again w…
STAT+: Pharmalittle: We’re reading about TrumpRx expectations, a high-dose version of Wegovy, and more
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
What happens after Ozempic shocked researchers
Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear. A large real-world study of nearly 8,000 patients found that most people who discontinue these drugs manage to keep the weight off—or even continue losing—by restarting treatment, switching medications, or adopting lifestyle changes. While earlier clinical trials suggested rapid weight regain, this new evidence paints a more hopeful picture.